In 2006, Sato et al. and Grimberg et al. found by analyzing lung cancer cells, that the IGFBP2 promoter has putative binding sites for early growth response protein 1 (EGR1) and transformation-related protein 53 (p53), that are crucial for its transactivation [8,10]. Here, TP53 is linked to lung cancer.